United Capital Financial Advisers, LLC Biogen Inc. Transaction History

United Capital Financial Advisers, LLC

$11.5 Billion
Q2 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Biogen Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 89,178 shares of BIIB stock, worth $15.5 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

89,178

Previous 91,376 2.41%

Holding current value

$15.5 Million

Previous $19.7 Million 4.92%

% of portfolio

0.18%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $418,762 - $520,310	-2,198 Reduced 2.41%	89,178 $20.7 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $825,605 - $1.04 Million	-3,894 Reduced 4.09%	91,376 $19.7 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $15.7 Million - $18.9 Million	-70,369 Reduced 42.48%	95,270 $24.7 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $5.36 Million - $6.05 Million	-21,170 Reduced 11.33%	165,639 $42.6 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $761,616 - $880,072	-2,767 Reduced 1.46%	186,809 $53.2 Million
Q1 2023 Aug 14, 2023	BUY	$256.56 - $292.34 $709,901 - $808,904	2,767 Added 1.48%	189,576 $52.7 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $605,994 - $690,507	-2,362 Reduced 1.23%	189,576 $52.7 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $2.42 Million - $2.94 Million	-9,592 Reduced 4.76%	191,938 $53.2 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $239,663 - $330,474	-1,231 Reduced 0.61%	201,530 $53.8 Million
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $551,742 - $656,124	2,942 Added 1.47%	202,761 $41.4 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $7.68 Million - $9.68 Million	39,640 Added 24.75%	199,819 $42.1 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $792,228 - $1.02 Million	3,538 Added 2.26%	160,179 $38.4 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $919,151 - $1.2 Million	3,248 Added 2.12%	156,641 $44.3 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $310,023 - $496,407	1,197 Added 0.79%	153,393 $53.1 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $5.2 Million - $6.09 Million	21,407 Added 16.37%	152,196 $42.6 Million
Q4 2020 Feb 17, 2021	BUY	$236.26 - $355.63 $846,519 - $1.27 Million	3,583 Added 2.82%	130,789 $32 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $2.55 Million - $2.94 Million	9,617 Added 8.18%	127,206 $36.1 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $3.61 Million - $4.78 Million	13,943 Added 13.45%	117,589 $31.5 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $946,083 - $1.2 Million	-3,519 Reduced 3.28%	103,646 $31.6 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $1.68 Million - $2.33 Million	7,654 Added 7.69%	107,165 $31.8 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $983,481 - $1.1 Million	4,523 Added 4.76%	99,511 $23.2 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $5.78 Million - $6.37 Million	26,360 Added 38.41%	94,988 $22.2 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $1.12 Million - $1.74 Million	5,146 Added 8.11%	68,628 $16.2 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $1.58 Million - $2 Million	5,680 Added 9.83%	63,482 $19.1 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $600,227 - $784,932	2,045 Added 3.67%	57,802 $20.4 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $663,371 - $790,600	2,576 Added 4.84%	55,757 $16.2 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $740,590 - $1.05 Million	2,847 Added 5.66%	53,181 $14.6 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $796,787 - $892,462	2,590 Added 5.42%	50,334 $16.1 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $771,194 - $904,339	2,743 Added 6.1%	47,744 $15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	45,001	45,001 $12.2 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Account

United Capital Financial Advisers, LLC Biogen Inc. Transaction History